PetVivo Holdings, Inc. (PETV): Cost of Revenue

Annual figures by period end, from SEC filings.

$386.9K
Year ended 2026-03-31
$390.3K
Trailing 12 months to 2026-06-30
+20.5%
3-year compound annual growth
+105.0%
5-year compound annual growth
2019-03-31: $77.9K2020-03-31: $19.7K2021-03-31: $10.7K2022-03-31: $201.2K2023-03-31: $221.0K2024-03-31: $101.8K2025-03-31: $137.7K2026-03-31: $386.9K$386.9K
2019-03-31 Cost of Revenue (USD) 2026-03-31
Period endedCost of RevenueChange YoYSource filing
2026-03-31$386.9K+181.0%2026-06-29, From 2025-04-01
2025-03-31$137.7K+35.2%2026-06-29, From 2024-04-01
2024-03-31$101.8K-53.9%2025-07-10, From 2023-04-01
2023-03-31$221.0K+9.9%2024-06-28, From 2022-04-01
2022-03-31$201.2Kn/m2023-06-29, From 2021-04-01
2021-03-31$10.7K-45.7%2022-06-24, From 2020-04-01
2020-03-31$19.7K-74.7%2021-06-29, From 2019-04-01
2019-03-31$77.9Kn/a2020-06-29, From 2018-04-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
PetVivo Holdings, Inc. (PETV)2026-03-31$386.9K+181.0%
RenovoRx, Inc. (RNXT)2025-12-31$327.0Kn/a
SeaStar Medical Holding Corp (ICU)2025-12-31$53.0Kn/a
Sintx Technologies, Inc. (SINT)2025-12-31$557.0K-31.3%
Flyte Aviation, Inc. (VJET)2025-12-31$63.0K+50.0%
EBR Systems, Inc. (NONE.)2025-12-31$1.13Mn/a
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31$646.0K+139.3%
Vycor Medical Inc (VYCO)2025-12-31$302.3K+81.2%
Co-Diagnostics, Inc. (CODX)2025-12-31$222.4K-77.7%

Compare PETV, RNXT, ICU, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗